Tag: interest

MAINZ and TÜBINGEN, Germany, June 12, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases based on messenger ribonucleic acid (“mRNA”). The all-stock transaction will bring together two highly complementary companies based in Germany and will build on BioNTech’s proven track record and established position in the global mRNA industry.

Driven by Stable Legacy Sales and Ongoing Cost Savings Initiatives

VANCOUVER, B.C., June 12, 2025 (GLOBE NEWSWIRE) -- Black Gold Exploration Corp. (the “Company” or “BGX”) (CSE: BGX) (OTCQB: BGXCF) (FRA: BLGX) is pleased to announce another significant development in its Illinois Basin operation. Through its joint venture partner LGX Energy Corp. (“LGX”), the Company has confirmed the presence of four discrete, hydrocarbon- bearing formations within a single vertical column at the now-producing Fritz 2-30 oil and gas well (the “Well”) in Clay County, Indiana, highlighting the potential for multi-zone development at the Well.

Hai Long offshore substation in the Taiwan Strait.

SANDWICH, United Kingdom, June 12, 2025 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis, is to present new data from its large-scale Phase II trial of LEVI-04 at EULAR, the European Congress of Rheumatology in Barcelona, Spain.